Clinical Trials: Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

This clinical trial will determine if Besifloxacin Ophthalmic Solution is an effective treatment for bacterial conjunctivitis.

Click here to access this third-party resource:

Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Study Type: Interventional

Age/Gender Requirements: 1 year+ (male/female)

Sponsor: Bausch & Lomb, Inc.

Purpose: This study will evaluate “the clinical and microbial efficacy of besifloxacin ophthalmic suspension compared with vehicle” for the treatment of bacterial conjunctivitis.